Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.0305161 on May 27, 2005

Published online before print May 27, 2005
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
jlb.0305161v1
78/2/442    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lim, J. K.
Right arrow Articles by DeVico, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lim, J. K.
Right arrow Articles by DeVico, A. L.
(Journal of Leukocyte Biology. 2005;78:442-452.)
© 2005 by Society for Leukocyte Biology

Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5

Jean K. Lim*,{dagger}, Jennifer M. Burns{ddagger}, Wuyuan Lu* and Anthony L. DeVico*,1

* Institute of Human Virology, University of Maryland Biotechnology Institute, and
{dagger} Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore; and
{ddagger} Chemocentryx, Inc., Mt. View, California

1 Correspondence: Institute of Human Virology, University of Maryland Biotechnology Institute, University of Maryland, 725 W. Lombard Street, Baltimore, MD 21201. E-mail: devico{at}umbi.umd.edu

The CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES)/CC chemokine ligand 5 (CCL5) is expressed by macrophages, endothelial cells, keratinocytes, and T cells during a wide variety of immune responses. Post-translational proteolysis is expected to play an important role in regulating such broad-based expression; however, the rates and modes of RANTES processing by primary cell systems remain poorly understood. Here, we show that peripheral blood mononuclear cells (PBMC) secrete RANTES as an intact molecule that is subject to three post-translational processing pathways. One occurs in the presence of serum or plasma and rapidly generates a RANTES variant lacking two N-terminal residues (3–68 RANTES). Such processing is mainly attributable to soluble CD26. A second pathway, which is evident in the absence of serum or plasma, generates 3–68 RANTES in concert with the expression of cell-surface CD26. The third pathway is unique and generates a novel variant lacking three N-terminal residues (4–68 RANTES). This variant binds CC chemokine receptor 5, exhibits reduced chemotactic and human immunodeficiency virus (HIV)-suppressive activity compared with 1–68 and 3–68 RANTES, and is generated by an unidentified enzyme associated with monocytes and neutrophils. Overall, these results indicate that the production of RANTES by primary cells is regulated by multiple processing pathways which produce two variants with different functional properties. Such findings have important implications for understanding the immunological and HIV-suppressive activities of native RANTES.

Key Words: chemokines • CD26 • protease • PBMC




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
J. K. Lim, W. Lu, O. Hartley, and A. L. DeVico
N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variant
J. Leukoc. Biol., December 1, 2006; 80(6): 1395 - 1404.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
I Tikhonov, C. Deetz, R Paca, S Berg, V Lukyanenko, J. Lim, and C. Pauza
Human V{gamma}2V{delta}2 T cells contain cytoplasmic RANTES
Int. Immunol., August 1, 2006; 18(8): 1243 - 1251.
[Abstract] [Full Text] [PDF]